FR2685919B1 - PROTEIN HAVING CYTOKINE ACTIVITY, RECOMBINANT DNA ENCODING THE PROTEIN, TRANSFORMED ANIMAL CELLS. - Google Patents

PROTEIN HAVING CYTOKINE ACTIVITY, RECOMBINANT DNA ENCODING THE PROTEIN, TRANSFORMED ANIMAL CELLS.

Info

Publication number
FR2685919B1
FR2685919B1 FR9200137A FR9200137A FR2685919B1 FR 2685919 B1 FR2685919 B1 FR 2685919B1 FR 9200137 A FR9200137 A FR 9200137A FR 9200137 A FR9200137 A FR 9200137A FR 2685919 B1 FR2685919 B1 FR 2685919B1
Authority
FR
France
Prior art keywords
protein
recombinant dna
dna encoding
animal cells
cytokine activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9200137A
Other languages
French (fr)
Other versions
FR2685919A1 (en
Inventor
Daniel Caput
Pascual Ferrara
Jean-Claude Guillemot
Mourad Kaghad
Bouteiller Christine Labit-Le
Pascal Leplatois
Marilyn Magazin
Adrian Minty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elf Sanofi SA
Original Assignee
Elf Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9200137A priority Critical patent/FR2685919B1/en
Application filed by Elf Sanofi SA filed Critical Elf Sanofi SA
Priority to MD97-0099A priority patent/MD1652G2/en
Priority to EP92400858A priority patent/EP0506574B1/en
Priority to ES92400858T priority patent/ES2054601T3/en
Priority to DK92400858.4T priority patent/DK0506574T3/en
Priority to HU9203753A priority patent/HU217099B/en
Priority to DE0506574T priority patent/DE506574T1/en
Priority to JP4507703A priority patent/JP2865423B2/en
Priority to CA002083826A priority patent/CA2083826C/en
Priority to DE69206301T priority patent/DE69206301T2/en
Priority to AT92400858T priority patent/ATE130869T1/en
Priority to PCT/FR1992/000280 priority patent/WO1992017586A1/en
Priority to IE921016A priority patent/IE72165B1/en
Priority to HU9203753A priority patent/HU9203753D0/en
Publication of FR2685919A1 publication Critical patent/FR2685919A1/en
Publication of FR2685919B1 publication Critical patent/FR2685919B1/en
Application granted granted Critical
Priority to GR940300052T priority patent/GR940300052T1/en
Priority to US08/371,121 priority patent/US5652123A/en
Priority to GR960400446T priority patent/GR3019043T3/en
Priority to HK98106615A priority patent/HK1007435A1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5437—IL-13
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5446—IL-16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B75/00—Other engines
    • F02B75/02—Engines characterised by their cycles, e.g. six-stroke
    • F02B2075/022—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle
    • F02B2075/027—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle four
FR9200137A 1991-03-29 1992-01-08 PROTEIN HAVING CYTOKINE ACTIVITY, RECOMBINANT DNA ENCODING THE PROTEIN, TRANSFORMED ANIMAL CELLS. Expired - Lifetime FR2685919B1 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
FR9200137A FR2685919B1 (en) 1992-01-08 1992-01-08 PROTEIN HAVING CYTOKINE ACTIVITY, RECOMBINANT DNA ENCODING THE PROTEIN, TRANSFORMED ANIMAL CELLS.
PCT/FR1992/000280 WO1992017586A1 (en) 1991-03-29 1992-03-27 Protein having a cytokinin-type activity, recombinant dna coding for this protein, transformed cells and micro-organisms
EP92400858A EP0506574B1 (en) 1991-03-29 1992-03-27 Protein having cytokin type activity, recombinant DNA coding for this protein, transformed cells and microorganisms
DK92400858.4T DK0506574T3 (en) 1991-03-29 1992-03-27 Protein with cytokine-type activity, recombinant DNA encoding this protein, cells and transformed microorganisms
HU9203753A HU217099B (en) 1991-03-29 1992-03-27 Process for producing a protein having cytokine-type activity, recombinant dna coding for this protein, transformed cells, and micro-organisms
DE0506574T DE506574T1 (en) 1991-03-29 1992-03-27 Protein with cytokine activity, encoding recombinant DNA, transformed cells and microorganisms.
JP4507703A JP2865423B2 (en) 1991-03-29 1992-03-27 Proteins having cytokine-type activity, and recombinant DNAs encoding the proteins, transformed cells and microorganisms
CA002083826A CA2083826C (en) 1991-03-29 1992-03-27 Protein having cytokine type activity, recombinant dna coding for this protein, transformed cells and microorganisms
DE69206301T DE69206301T2 (en) 1991-03-29 1992-03-27 Protein with the activity of the cytokine type, encoding recombinant DNA, transformed cells and microorganisms.
AT92400858T ATE130869T1 (en) 1991-03-29 1992-03-27 PROTEIN WITH CYTOKINE-TYPE ACTIVITY, RECOMBINANT DNA CODING FOR IT, TRANSFORMED CELLS AND MICROORGANISMS.
MD97-0099A MD1652G2 (en) 1991-03-29 1992-03-27 Protein possessing the cytokin - type activity, recombinant DNA-codifyer for such protein, transformed cells and microorganism, expression vector, process for protein obtaining and remedy containing such a protein
ES92400858T ES2054601T3 (en) 1991-03-29 1992-03-27 PROTEIN WITH CYTOKINE TYPE ACTIVITY, RECOMBINANT DNA CODE FOR THIS PROTEIN, CELLS AND TRANSFORMED MICROORGANISMS.
IE921016A IE72165B1 (en) 1991-03-29 1992-03-30 Protein having cytokine type activity recombinant DNA coding for this protein and transformed animal cells
HU9203753A HU9203753D0 (en) 1991-03-29 1992-11-27 Protein having cytoqinic-like effect recombinant dna sequence coding it corresponding transformed cells and micro-organisms
GR940300052T GR940300052T1 (en) 1991-03-29 1994-08-31 Protein having cytokin type activity, recombinant DNA coding for this protein, transformed cells and microorganisms.
US08/371,121 US5652123A (en) 1991-03-29 1995-01-11 Protein having interleukin 13 activity, recombinant DNA coding for this protein, transformed cells and microorganisms
GR960400446T GR3019043T3 (en) 1991-03-29 1996-02-21 Protein having cytokin type activity, recombinant DNA coding for this protein, transformed cells and microorganisms.
HK98106615A HK1007435A1 (en) 1991-03-29 1998-06-25 Protein having cytokin type activity recombinant dna coding for this protein transformed cells and microorganisms

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9200137A FR2685919B1 (en) 1992-01-08 1992-01-08 PROTEIN HAVING CYTOKINE ACTIVITY, RECOMBINANT DNA ENCODING THE PROTEIN, TRANSFORMED ANIMAL CELLS.

Publications (2)

Publication Number Publication Date
FR2685919A1 FR2685919A1 (en) 1993-07-09
FR2685919B1 true FR2685919B1 (en) 1994-04-08

Family

ID=9425477

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9200137A Expired - Lifetime FR2685919B1 (en) 1991-03-29 1992-01-08 PROTEIN HAVING CYTOKINE ACTIVITY, RECOMBINANT DNA ENCODING THE PROTEIN, TRANSFORMED ANIMAL CELLS.

Country Status (1)

Country Link
FR (1) FR2685919B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0616359B8 (en) 2005-09-30 2022-08-30 Medimmune Ltd PHARMACEUTICAL COMPOSITION, PROCESS FOR PURIFICATION OF AN IL-13 ANTIBODY AND USE OF A PHARMACEUTICAL COMPOSITION CONTAINING AN ANTIBODY

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL92685A0 (en) * 1988-12-16 1990-09-17 Us Commerce Dna encoding lymphokine/cytokine like proteins,cells transformed thereby and production of said proteins and antibodies against them

Also Published As

Publication number Publication date
FR2685919A1 (en) 1993-07-09

Similar Documents

Publication Publication Date Title
NO891818D0 (en) T4 RECEPTOR PROTEIN, RELATED DNA SEQUENCES AND PREPARATION thereof.
DE3587864T2 (en) RECOMBINANT DNA MOLECULES.
MA22905A1 (en) NEW DNA SEQUENCES.
DE3883041T2 (en) Stable gene amplification in prokaryotic chromosonal DNA.
DE3874277T2 (en) ACTIVE MULTIFUNCTIONAL ANTENNA GROUP.
DE68922501T2 (en) Enzyme electrode.
NO882226L (en) FIBRINOLYTIC PROTEINS.
FR2692268B1 (en) New polypeptides having NMDA receptor activity, nucleic acids encoding these polypeptides and uses.
DE3863085D1 (en) ANTHELMINTHIC ACTIVE COMBINATIONS.
DE3781140T2 (en) PLATE-SHAPED, ION-SENSITIVE ELECTRODE.
NO882766D0 (en) CATALYSTS AND PROCEDURES FOR THEIR PREPARATION.
DE3887656D1 (en) Lipase gene.
FR2696749B1 (en) New polypeptides having serotonergic receptor activity, nucleic acids encoding these polypeptides and uses.
DE69023430D1 (en) Enzyme electrode.
FR2681076B1 (en) RECOMBINANT DNA ENCODING PROTEIN WITH ENDOCHITINASE ACTIVITY.
FI883714A (en) STABILIZER FOER ELEKTROSTATISKA, FLYTANDE FRAMKALLARE.
FR2685919B1 (en) PROTEIN HAVING CYTOKINE ACTIVITY, RECOMBINANT DNA ENCODING THE PROTEIN, TRANSFORMED ANIMAL CELLS.
FR2674537B1 (en) PROTEIN HAVING CYTOKINE ACTIVITY, RECOMBINANT DNA ENCODING THE PROTEIN, TRANSFORMED ANIMAL CELLS.
DE69114145D1 (en) CATALYTIC HYDROGENOLYSIS.
FI895456A0 (en) RECOMBINANT INTERLEUKIN 2-HYBRIDPROTEINER.
DE3860085D1 (en) MULTIPART CYLINDERS.
FI893450A0 (en) PROTEIN MODIFICATION.
FI883254A (en) CYTOSTATISKT ACTIVE ANTHRACYCLINDERIVAT.
FR2701265B1 (en) New polypeptides having serotoninergic receptor activity, nucleic acids encoding these polypeptides and uses.
FR2693201B1 (en) New polypeptides having serotonergic receptor activity, nucleic acids encoding these polyptides and uses.

Legal Events

Date Code Title Description
AV Other act affecting the existence or the validity of an industrial property right
CL Concession to grant licenses
CA Change of address
CD Change of name or company name
TP Transmission of property
CD Change of name or company name